AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Evercore stock, investors need to believe in the firm's ability to capture upside as global transaction activity rebounds and capital markets stabilize. The recent US$250,000,000 private debt placement, earmarked for refinancing and general purposes, strengthens Evercore's balance sheet but is unlikely to materially shift the biggest short-term catalyst, market normalization, and does little to offset the principal risk posed by external macroeconomic headwinds dampening deal flow and earnings growth.
One announcement closely linked to this backdrop is Evercore’s ongoing expansion of its senior talent bench through high-profile hires in Industrials, Healthcare, and Private Capital Advisory. This move aligns with the theme that, should market conditions improve, investments in sector expertise can accelerate performance against headwinds to transaction volumes and revenue potential.
By contrast, investors should be aware that even with solid refinancing, returns could be squeezed if...
Read the full narrative on Evercore (it's free!)
Evercore's narrative projects $4.4 billion revenue and $728.3 million earnings by 2028. This requires 12.8% yearly revenue growth and a $289.5 million earnings increase from $438.8 million today.
Uncover how Evercore's forecasts yield a $318.33 fair value, a 7% upside to its current price.
Simply Wall St Community members produced three fair value estimates for Evercore, ranging from US$271.03 to US$331 per share. While assessors differ, many will be watching whether the company’s ability to maintain revenue growth above market forecasts can outpace persistent volatility in global capital markets.
Explore 3 other fair value estimates on Evercore - why the stock might be worth as much as 11% more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Discover if Evercore might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。